MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)
Clinical trial NCT01028586 · TERMINATED
Trial details
- NCT number
- NCT01028586
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2012-05-01
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.